{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T07:31:58Z","timestamp":1767598318665,"version":"3.44.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100010613","name":"Taipei Medical University Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010613","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014804","name":"Mackay Medical College","doi-asserted-by":"publisher","award":["MMC-RD-109-CF-G2-01","MMC-RD-110-CF-G002-01"],"award-info":[{"award-number":["MMC-RD-109-CF-G2-01","MMC-RD-110-CF-G002-01"]}],"id":[{"id":"10.13039\/501100014804","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018493","name":"Taipei Medical University Shuang Ho Hospital","doi-asserted-by":"publisher","award":["111TMU-TMUH-03-4"],"award-info":[{"award-number":["111TMU-TMUH-03-4"]}],"id":[{"id":"10.13039\/100018493","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["MOST 109-2320-B-038-054","MOST 110-2320-B-038-086"],"award-info":[{"award-number":["MOST 109-2320-B-038-054","MOST 110-2320-B-038-086"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"Ministry of Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thrombosisresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.thromres.2023.03.017","type":"journal-article","created":{"date-parts":[[2023,3,31]],"date-time":"2023-03-31T20:32:31Z","timestamp":1680294751000},"page":"63-72","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Paclitaxel exerts antiplatelet and antithrombotic activities: Additional benefit from use of paclitaxel-coated balloons and -eluting stents in coronary revascularization and prevention of in-stent restenosis"],"prefix":"10.1016","volume":"225","author":[{"given":"Kuan-Hung","family":"Lin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiun-Yi","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ray-Jade","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting-Yu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shao-Hsuan","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hsueh-Hsiao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hsien-Yu","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Yo","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wan-Jung","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl 1","key":"10.1016\/j.thromres.2023.03.017_bb0005","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/j.1538-7836.2007.02517.x","article-title":"Platelets, inflammation and atherosclerosis","volume":"5","author":"Lindemann","year":"2007","journal-title":"J. Thromb. Haemost."},{"issue":"Suppl 1","key":"10.1016\/j.thromres.2023.03.017_bb0010","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/j.1538-7836.2011.04361.x","article-title":"Platelet adhesion and activation mechanisms in arterial thrombosis and ischaemic stroke","volume":"9","author":"Nieswandt","year":"2011","journal-title":"J. Thromb. Haemost."},{"issue":"3","key":"10.1016\/j.thromres.2023.03.017_bb0015","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/nrcardio.2017.206","article-title":"Current and future antiplatelet therapies: emphasis on preserving haemostasis","volume":"15","author":"McFadyen","year":"2018","journal-title":"Nat. Rev. Cardiol."},{"issue":"10","key":"10.1016\/j.thromres.2023.03.017_bb0020","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1056\/NEJM199303113281001","article-title":"A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. The Primary Angioplasty in Myocardial Infarction Study Group","volume":"328","author":"Grines","year":"1993","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.thromres.2023.03.017_bb0025","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1161\/CIRCINTERVENTIONS.110.959882","article-title":"Restenosis: delineating the numerous causes of drug-eluting stent restenosis","volume":"4","author":"Farooq","year":"2011","journal-title":"Circ. Cardiovasc. Interv."},{"issue":"10 Suppl","key":"10.1016\/j.thromres.2023.03.017_bb0030","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.jacc.2010.06.007","article-title":"Coronary stents: current status","volume":"56","author":"Garg","year":"2010","journal-title":"J. Am. Coll. Cardiol."},{"issue":"4","key":"10.1016\/j.thromres.2023.03.017_bb0035","first-page":"488","article-title":"Differences of platelet adhesion and thrombus activation on amorphous silicon carbide, magnesium alloy, stainless steel, and cobalt chromium stent surfaces","volume":"73","author":"Hansi","year":"2009","journal-title":"Catheter. Cardiovasc. Interv."},{"issue":"10","key":"10.1016\/j.thromres.2023.03.017_bb0040","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1056\/NEJMoa067193","article-title":"Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents","volume":"356","author":"Stone","year":"2007","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.thromres.2023.03.017_bb0045","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1161\/01.CIR.94.7.1690","article-title":"Marked inflammatory sequelae to implantation of biodegradable and nonbiodegradable polymers in porcine coronary arteries","volume":"94","author":"van der Giessen","year":"1996","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.thromres.2023.03.017_bb0050","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1161\/CIRCULATIONAHA.104.508937","article-title":"Differential response of delayed healing and persistent inflammation at sites of overlapping sirolimus- or paclitaxel-eluting stents","volume":"112","author":"Finn","year":"2005","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.thromres.2023.03.017_bb0055","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1093\/eurheartj\/ehr479","article-title":"Lower risk of stent thrombosis and restenosis with unrestricted use of 'new-generation' drug-eluting stents: a report from the nationwide Swedish Coronary Angiography and Angioplasty Registry (SCAAR)","volume":"33","author":"Sarno","year":"2012","journal-title":"Eur. Heart J."},{"issue":"21","key":"10.1016\/j.thromres.2023.03.017_bb0060","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.1016\/j.jacc.2020.04.006","article-title":"Drug-coated balloon angioplasty versus drug-eluting stent implantation in patients with coronary stent restenosis","volume":"75","author":"Giacoppo","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"issue":"3","key":"10.1016\/j.thromres.2023.03.017_bb0065","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S0735-1097(99)00596-3","article-title":"Platelets and restenosis","volume":"35","author":"Chandrasekar","year":"2000","journal-title":"J. Am. Coll. Cardiol."},{"issue":"1","key":"10.1016\/j.thromres.2023.03.017_bb0070","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/nrcardio.2011.132","article-title":"Restenosis after PCI. Part 1: pathophysiology and risk factors","volume":"9","author":"Jukema","year":"2011","journal-title":"Nat. Rev. Cardiol."},{"issue":"4","key":"10.1016\/j.thromres.2023.03.017_bb0075","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/0735-1097(95)00563-3","article-title":"Neutrophil and platelet activation at balloon-injured coronary artery plaque in patients undergoing angioplasty","volume":"27","author":"Neumann","year":"1996","journal-title":"J. Am. Coll. Cardiol."},{"issue":"10","key":"10.1016\/j.thromres.2023.03.017_bb0080","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/S0002-9149(00)01159-0","article-title":"Comparison of activation process of platelets and neutrophils after coronary stent implantation versus balloon angioplasty for stable angina pectoris","volume":"86","author":"Inoue","year":"2000","journal-title":"Am. J. Cardiol."},{"issue":"1","key":"10.1016\/j.thromres.2023.03.017_bb0085","doi-asserted-by":"crossref","first-page":"21420","DOI":"10.1038\/s41598-020-77934-x","article-title":"The antiplatelet agent revacept prevents the increase of systemic thromboxane A2 biosynthesis and neointima hyperplasia","volume":"10","author":"Alberti","year":"2020","journal-title":"Sci. Rep."},{"issue":"8","key":"10.1016\/j.thromres.2023.03.017_bb0090","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1161\/hc0802.105256","article-title":"Platelets activated by collagen through immunoreceptor tyrosine-based activation motif play pivotal role in initiation and generation of neointimal hyperplasia after vascular injury","volume":"105","author":"Konishi","year":"2002","journal-title":"Circulation"},{"issue":"15","key":"10.1016\/j.thromres.2023.03.017_bb0095","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1056\/NEJM199504133321507","article-title":"Paclitaxel (taxol)","volume":"332","author":"Rowinsky","year":"1995","journal-title":"N. Engl. J. Med."},{"issue":"15","key":"10.1016\/j.thromres.2023.03.017_bb0100","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1093\/jnci\/82.15.1247","article-title":"Taxol: a novel investigational antimicrotubule agent","volume":"82","author":"Rowinsky","year":"1990","journal-title":"J. Natl. Cancer Inst."},{"issue":"2","key":"10.1016\/j.thromres.2023.03.017_bb0105","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1161\/01.CIR.96.2.636","article-title":"Paclitaxel inhibits arterial smooth muscle cell proliferation and migration in vitro and in vivo using local drug delivery","volume":"96","author":"Axel","year":"1997","journal-title":"Circulation"},{"issue":"38","key":"10.1016\/j.thromres.2023.03.017_bb0110","doi-asserted-by":"crossref","first-page":"3740","DOI":"10.1093\/eurheartj\/ehz881","article-title":"The paclitaxel story in cardiovascular medicine","volume":"41","author":"Baumgartner","year":"2020","journal-title":"Eur. Heart J."},{"issue":"9","key":"10.1016\/j.thromres.2023.03.017_bb0115","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.jacc.2019.11.065","article-title":"Survival after coronary revascularization with paclitaxel-coated balloons","volume":"75","author":"Scheller","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"issue":"3","key":"10.1016\/j.thromres.2023.03.017_bb0120","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s12272-010-0307-1","article-title":"The protective effects of paclitaxel on platelet aggregation through the inhibition of thromboxane A2 synthase","volume":"33","author":"Lee","year":"2010","journal-title":"Arch. Pharm. Res."},{"issue":"3","key":"10.1016\/j.thromres.2023.03.017_bb0125","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1093\/cvr\/cvp139","article-title":"Mechanisms of resveratrol-induced platelet apoptosis","volume":"83","author":"Lin","year":"2009","journal-title":"Cardiovasc. Res."},{"issue":"7","key":"10.1016\/j.thromres.2023.03.017_bb0130","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.3390\/ijms18071500","article-title":"Licochalcone A prevents platelet activation and thrombus formation through the inhibition of PLCgamma2-PKC, Akt, and MAPK pathways","volume":"18","author":"Lien","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.thromres.2023.03.017_bb0135","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1096\/fj.07-9574LSF","article-title":"Dose translation from animal to human studies revisited","volume":"22","author":"Reagan-Shaw","year":"2008","journal-title":"FASEB J."},{"issue":"7","key":"10.1016\/j.thromres.2023.03.017_bb0140","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nmeth.2089","article-title":"NIH Image to ImageJ: 25 years of image analysis","volume":"9","author":"Schneider","year":"2012","journal-title":"Nat. Methods"},{"issue":"19","key":"10.1016\/j.thromres.2023.03.017_bb0145","doi-asserted-by":"crossref","first-page":"9434","DOI":"10.1111\/jcmm.16886","article-title":"A novel naphthalimide derivative reduces platelet activation and thrombus formation via suppressing GPVI","volume":"25","author":"Shih","year":"2021","journal-title":"J. Cell. Mol. Med."},{"issue":"15","key":"10.1016\/j.thromres.2023.03.017_bb0150","doi-asserted-by":"crossref","first-page":"12874","DOI":"10.1074\/jbc.M200482200","article-title":"Protein kinase B is regulated in platelets by the collagen receptor glycoprotein VI","volume":"277","author":"Barry","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"49","key":"10.1016\/j.thromres.2023.03.017_bb0155","doi-asserted-by":"crossref","first-page":"33763","DOI":"10.1074\/jbc.M109.048553","article-title":"Role of phosphoinositide 3-kinase beta in glycoprotein VI-mediated akt activation in platelets","volume":"284","author":"Kim","year":"2009","journal-title":"J. Biol. Chem."},{"issue":"9","key":"10.1016\/j.thromres.2023.03.017_bb0160","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1111\/jth.14967","article-title":"Platelet MAPKs a 20+year history: what do we really know?","volume":"18","author":"Patel","year":"2020","journal-title":"J. Thromb. Haemost."},{"issue":"12","key":"10.1016\/j.thromres.2023.03.017_bb0165","doi-asserted-by":"crossref","first-page":"3611","DOI":"10.1182\/blood-2004-04-1549","article-title":"Regulation of platelet membrane levels of glycoprotein VI by a platelet-derived metalloproteinase","volume":"104","author":"Gardiner","year":"2004","journal-title":"Blood"},{"issue":"5698","key":"10.1016\/j.thromres.2023.03.017_bb0170","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/277665a0","article-title":"Promotion of microtubule assembly in vitro by taxol","volume":"277","author":"Schiff","year":"1979","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.thromres.2023.03.017_bb0175","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1073\/pnas.77.3.1561","article-title":"Taxol stabilizes microtubules in mouse fibroblast cells","volume":"77","author":"Schiff","year":"1980","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"9\u201310","key":"10.1016\/j.thromres.2023.03.017_bb0180","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s10495-022-01750-z","article-title":"Mechanisms of cancer cell death induction by paclitaxel: an updated review","volume":"27","author":"Zhao","year":"2022","journal-title":"Apoptosis"},{"issue":"18","key":"10.1016\/j.thromres.2023.03.017_bb0185","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1091\/mbc.e14-04-0916","article-title":"How Taxol\/paclitaxel kills cancer cells","volume":"25","author":"Weaver","year":"2014","journal-title":"Mol. Biol. Cell"},{"issue":"4","key":"10.1016\/j.thromres.2023.03.017_bb0190","first-page":"816","article-title":"Mitotic block induced in HeLa cells by low concentrations of paclitaxel (Taxol) results in abnormal mitotic exit and apoptotic cell death","volume":"56","author":"Jordan","year":"1996","journal-title":"Cancer Res."},{"issue":"19","key":"10.1016\/j.thromres.2023.03.017_bb0195","first-page":"5349","article-title":"Paclitaxel induces release of cytochrome c from mitochondria isolated from human neuroblastoma cells'","volume":"60","author":"Andre","year":"2000","journal-title":"Cancer Res."},{"issue":"1\u20132","key":"10.1016\/j.thromres.2023.03.017_bb0200","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/S0014-5793(02)03691-8","article-title":"Paclitaxel targets mitochondria upstream of caspase activation in intact human neuroblastoma cells","volume":"532","author":"Andre","year":"2002","journal-title":"FEBS Lett."},{"issue":"22","key":"10.1016\/j.thromres.2023.03.017_bb0205","doi-asserted-by":"crossref","first-page":"19555","DOI":"10.1074\/jbc.M011164200","article-title":"Paclitaxel induces prolonged activation of the Ras\/MEK\/ERK pathway independently of activating the programmed cell death machinery","volume":"276","author":"Okano","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.thromres.2023.03.017_bb0210","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0021-9150(95)05562-B","article-title":"Kinetics of smooth muscle cell proliferation and intimal thickening in a pig carotid model of balloon injury","volume":"117","author":"Groves","year":"1995","journal-title":"Atherosclerosis"},{"issue":"10","key":"10.1016\/j.thromres.2023.03.017_bb0215","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1016\/j.biomaterials.2010.12.025","article-title":"The inhibition of platelet adhesion and activation on collagen during balloon angioplasty by collagen-binding peptidoglycans","volume":"32","author":"Paderi","year":"2011","journal-title":"Biomaterials"}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384823000920?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384823000920?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T17:50:14Z","timestamp":1758736214000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384823000920"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":43,"alternative-id":["S0049384823000920"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2023.03.017","relation":{},"ISSN":["0049-3848"],"issn-type":[{"type":"print","value":"0049-3848"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Paclitaxel exerts antiplatelet and antithrombotic activities: Additional benefit from use of paclitaxel-coated balloons and -eluting stents in coronary revascularization and prevention of in-stent restenosis","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2023.03.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}